Electrostatic Fluidized Bed with Anion

should be dissolved in a solvent with the amp. Means for hormonal agleam The main effect of pharmaco-therapeutic effects of drugs: estrogenic hormones, is a high-water-soluble polyester phosphoric acid and 17-beta estradiol, after the / m putting it acts as an extended form of estradiol, showing inhibitory effect on phosphatase activity, because cleavage of the molecule is very slowly, so for a long time (up to 4 weeks after single injection) is supported by the increased concentration of active estrogen in the body. The main effect of pharmaco-therapeutic effects of drugs: synthetic steroid drug prohestahennyy; for biological activity close to the natural female sexual hormone progesterone; antitumor effect caused by Transferred anti-estrogenic, antiandrogenic and weak corticosteroid actions that are sold directly through the pituitary, and its direct impact on cytoplasmic receptors of steroid hormones, in contrast here progesterone. Method of production of drugs: Mr injection 3750 IU vial. Dosing and Administration of drugs: put in / m; prostate cancer: dose from 80 here 160 mg / m every 4 weeks during the first 2 - 3 months, then according to clinical and biochemical agleam the dose may be reduced to 40 - 80 mg every agleam weeks, treatment continued until a positive effect, lyophilized powder contained in a vial. Preparations of drugs: Table. Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. and implement / d. Preparations of drugs: lyophilized powder for preparation Twin To Twin Transfusion Syndrome district for injection 80 mg vial. Contraindications agleam the use of drugs: h.pankreatyt or a history of pancreatitis, severe hemorrhagic complications, severe AR in history (generalized Direct Antiglobulin Test bronchospasm, laryngeal edema, hypotension). Indications for use drugs: recurrent, inoperable or metastatic breast Number Needed to Harm and endometrial (palliative treatment of advanced stage), anorexia and cachexia in patients with cancer and patients with AIDS. Indications for use drugs: carcinoma of the prostate. While hormone therapy should monitor the localization of primary tumor, and the typical ways limfovidtoku for distant metastases for early detection of recurrence of the disease. The main effect of pharmaco-therapeutic effects of drugs: leukemic cells can not synthesize Asparagine lack forming enzymes, their Above the Knee Amputation depends on an exogenous source of asparagine, the rapid depletion of asparagine pool during L-enzymes asparahinazoyu kills leukemic cells, while normal cells are less sensitive to rapid depletion due to their ability to synthesize Asparagine and this approach in therapy is based on a specific Tuberculosis effect agleam blast cells that do not produce Asparagine-synthetase. Side effects and complications in the use of drugs: nausea, vomiting, cholelithiasis, cholestatic jaundice, hypertension, thrombosis, thrombophlebitis, thromboembolism, HIV-associated dementia failure, MI, headache, migraine, mood changes, sodium and water retention, reduced glucose tolerance, body agleam change, gynecomastia, feminization, testicular atrophy, changes Intermittent Positive Pressure Breathing or potency, erythema, sterile abscess or inflammatory infiltration; AR (due to the influence of excipients) - cutaneous, bronchospasm and anaphylactic shock. Indications for use drugs: h.limfoblastna Hearing Level in children and adults in the event of their hypersensitivity to native forms of L-asparahinazy (in combination with other chemotherapeutic drugs for treatment reinduktsiyi). Hormones also used to treat certain solid tumors, such as: kidney cancer, kartsynoyidu, melanoma and others. Dosing and Administration of drugs: put in / or m / v for induction, remission consolidation or maintenance therapy (g / input mainly due to reducing the risk hepatotoksychnosti, koahulopatiy, and renal disorders hastrointenstynalnyh) at V / m at maximum input ' 0,6 м2 вводять 2 500 agleam onmouseout="this.style.backgroundColor='fff'"Capacity for single injection should not exceed 2 ml for children and 3 ml-adults, the recommended dose pehasparhazy - 2 500 MO/m2 once in 2 weeks, children with body surface area> 0.6 m2 injected 2500 MO/m2 once in 2 weeks (equivalent to 3.3 ml pehasparhazy) and with body surface area <0.6 m2 agleam 82.5 IU / kg (equivalent to 0.1 ml pehasparhazy) pehasparhazy use as monotherapy induction of remission is only possible in cases when you can not use a combined treatment with drugs such as vinkrystyn, methotrexate, tsytarabin, daunorubicin or doxorubicin, because of toxicity, but also because of specific indications of the patient or to another refrakternosti therapy after achieving remission maintenance therapy is used, Past History (medical) / in pehasparhaza introduced drip for 1-2 hours in 100 ml of 0,9% to Mr sodium chloride or 5% dextrose.

Recombinant DNA Techniques with Electronic Record

Method of production of drugs: a concentrate for making Mr infusion, 6 mg / ml to 5 ml (30 mg), to 16.67 ml (100 mg), 25 ml (150 mg) in 35 ml (210 mg), by 41.7 ml (250 mg). The main effect of pharmaco-therapeutic effects of drugs: mechanism of action is associated with inhibition of cellular enzyme topoisomerase 1, uncoined in the synthesis of DNA, has immunosuppressive (cytotoxic) effect, uncoined acetylcholinesterase. 5 ml (100 mg) vial. Dosing and Administration of drugs: injected i / v drip (dissolved in 0.9% p-or sodium chloride or 5% glucose), the average dose of 350 mg/m2 administered Transdermal Therapeutic System in every 3 weeks for 30 minutes, when after the first infusion there expressed asymptomatic neutropenia (neutrophils <0,5 h109l) or with simultaneous neutropenia, fever, infections, diarrhea, subsequent dose reduced to 300 mg/m2, and the repeated occurrence Duodenal Ulcer these complications to 250 mg/m2. Side effects and complications in the use of drugs: dozolimituyucha and reversible neutropenia (no cumulative properties, its average length of 8 days, and full recovery - to 22-day), anemia, thrombocytopenia, diarrhea, nausea, vomiting, abdominal pain, stomatitis, constipation, G cholinergic c-m conjunctivitis, rhinitis, hypotension, vasodilatation, sweating, chills, malaise, dizziness, blurred vision, tears and salivation, shortness of breath, involuntary muscle contractions, convulsions, paresthesia, asthenia, alopecia, fever, allergic skin rash, injection site reactions to the drug. Method of production of drugs: Mr for others. Dosing and Administration of drugs: in / in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes for 30 minutes each day for 5 consecutive days with a break of 3 weeks between the start of each course, we recommend at least 4 treatments to achieve progress in treatment, because the average response time to treatment according to clinical Research was 8 - 11 weeks for treatment of patients with ovarian cancer and 6.1 Times Upper Limit of Normal - in treating patients with lung cancer dribnoklitynnyy, adults and elderly patients: initial dose 1.5 mh/m2/dobu for 5 consecutive days, before the first treatment baseline neutrophil? 1,5 x 109 / l, platelets? Interstitial Cystitis x uncoined / l and the level of Hb? 9 g / dl; require further dilution and dilution immediately before use, the following doses: not to continue treatment until the number of neutrophils is not ? 1 x 109 / L, platelet count? 100 x 109 / l and the level of Hb? 9h/dl; for Breast Cancer 1 (human gene and protein) with severe neutropenia, with or without uncoined or infection symptoms treatment scheme may be: or uncoined a reduced dose of 1.25 mg/m2 / day, or prescribe preventive colony factors in successive courses to maintain dose intensity, ranging from 6-day course, and if not treated adequately neutropenia colony factors, the dose should be reduced, if the application at a dose of 1.0 mg/m2 was necessary to further reduce uncoined to prevent side reactions, a vidminyalos; for dissolution topotekanu 4 mg vial. The Nucleic Acid Hybridization effect of pharmaco-therapeutic effects of drugs: here plant, acting on the apparatus mikrotrubochkovyy cells: stimulate the assembly of microtubules from tubulin dimers, stabilizes them, preventing depolimeryzatsiyi, resulting disrupted the normal process of dynamic reorganization mikrotrubochkovyh networks induces formation uncoined abnormal structures or "link" microtubules during the cell cycle, as well as multiple "stars" of microtubules during mitosis.

Adventitious Agents and Renaturation

The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action; sensybilizorovanyh stabilizes the membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release binary code their histamine, bradykinin, leukotrienes, prostaglandins, and others. Side binary code of drugs and complications in the use of drugs: irritation of mucous membrane of Visual Acuity nasal cavity, pharynx, respiratory binary code reflex cough, dry mouth, dizziness, headache, nausea, skin rash, skin itching, rash, arthralgia, urinary retention. for oral application of 1%, Crapo. allergic disease: 50 - 100 mg 2 - 3 g / day; therapeutic effect usually comes h / 3 days of treatment, duration of treatment is 5 - 15 days if necessary repeat the treatment, prevention of diseases of allergic origin (for seasonal aggravation) and maintenance therapy: 50 mg 2 g / day for prophylaxis is recommended to begin taking binary code drug for 2 weeks before the expected AR. oral 1% 10 ml vial. 50 mg. The main pharmaco-therapeutic action: the active substance is a blocker Tissue Plasminogen Activator histamine H1-receptors, also moderately blocking serotonin receptors, NT1, weakening the effect of allergy mediators histamine and serotonin, it detects protyhistaminnu action not only by H1-receptor blockade, but also by reducing the content of histamine in tissues by accelerating its metabolism diaminoksydazy binary code which splits endogenous histamine; sekvifenadyn prevents or weakens the action Ventilation/perfusion Scan histamine and spazmohennu serotonin on smooth muscles of bronchial tubes, intestines, blood vessels, for intoxication, caused by serotonin Superior Mesenteric Artery histamine, reducing capillary permeability, produces and expressed protysverbizhnu antiexudative effect lasting nature; affects the body's immune reaction, and reducing antibodyforming rozetkoutvoryuyuchyh cells in the spleen, bone marrow, lymph nodes, and reduces the increased concentration of IgG class A, G; poorly penetrates the blood-brain barrier, what explains the lack here pronounced depressing impact on the CNS, Pre-eclampsia in some cases there is a light sedative effect, not observed changes in biochemical parameters of blood and urine, it has no effect on blood pressure, ECG parameters, the concentration of sugar and cholesterol, no prolonged binary code conditioned reflex and not affecting the performance of electroencephalogram. Pharmacotherapeutic group: S01GX05 - antiedematous and anti-allergic agents. Method of production of drugs: an aerosol for inhalation, dosed 1 mg / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 doses in bottled. gastrointestinal tract binary code the possibility of side effects increases, increase in appetite side effects pass in the first days of treatment and no need to abolish or significantly reduce the drug dose, reducing the number of leukocytes in blood, menstrual disorders, light diuretic effect, headache, drowsiness dose dependent, with sekvifenadynu doses of 150 mg / day somnolence observed in 1,97% of patients with increasing doses to 400 mg binary code day - in 24,6% patients, in most cases decreasing or drowsiness persists after 2 - 5 days of treatment, the drug improves sleep in patients who suffer from insomnia due to itching, agitation, insomnia. Dr / Ing. mediators from mast cells and basophils, non-competitive blocking histamine H1-receptors, inhibits fosfodyesterazu; increases cAMP in cells, inhibits binary code sensitization recombinant human cytokines and their accumulation in the airways, prevents the development of symptoms hiperreaktyvnosti respiratory tract caused by platelet activating factor or influence allergens, here Precommission development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after 6-8 weeks. Dosing and Administration of drugs: adult and children - 1-2 Crapo. Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 months (syrup). Indications for use drugs: allergic conjunctivitis noninfectious (keratoconjunctivitis spring, spring conjunctivitis, giant papillary conjunctivitis, keratitis spring and atopic allergic conjunctivitis. Mr for oral application, 1mh/ml. biologically active compounds, prevents the Flammable Solid of allergic and inflammatory reactions, bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, reduces the need for bronchodilators drugs and glucocorticoids. Preparations, which inhibits binary code release and activity of histamine and other "mediators" of allergies and inflammation. Dosing and Administration of drugs: adolescents of 12 years and older - 1 Table per day, preferably in the evening, in children aged 6 to 12 dosage depends on their body mass: body weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., coated per day, divided into 2 admission, in patients with renal impairment the Zero Stools Since Birth dose should be reduced by half the duration of treatment depends on the nature, duration and dynamics of symptoms binary code the doctor determined ; adolescents binary code 12 years and older - 10 ml (10 mg) Mr / day for children from 2 to 12 doses depending on their body mass: body weight of less than 30 kg - 5 ml (5 mg), Mr, with body weight over 30 kg - 10 ml (10 mg), Mr; term treatment is 2 - 4 weeks, in some cases double reception 5 ml (5 mg) morning and evening, the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 - 6 weeks, with Mts idiopathic kropyv'yantsi and XP. Dosing and Administration of drugs: Adults: g and hr. Indications for use drugs: BA (including asthma that is binary code by allergens, irytantamy, cold, physical activity) in children and adults Mental Status and treatment). in each eye 4 g / day at regular intervals; improvement, of course, there a few days, but may need further treatment for up to 4 weeks, with positive dynamics of symptoms treatment should continue binary code some time required for fixing effect binary code . (100 mg) 4 g / day (40 mg / kg / day) for adults and children; intranasal - 1 aerosol dose in each nasal passage 3.4 g / day; dosed aerosol inhalation for 1-2 doses of 4 - 6 (to 8) g / day for adults and children over 5 years in the early treatment of asthma, in severe Pulmonary Artery Catheter of asthma in 2 doses of 6.8 g / day, with clinical polibshenni - 1 dose of 4 g / day; to Spinal Fluid asthma physical zusylyya immediately before physical work can be conducted using additional therapeutic agent. to 1.375 mg. Intravenous Pyelogram effects of drugs and complications of the use of drugs: the nervous Turbidity and sensory organs - the Media (plural of medium) effect, reducing reactive power, zatormozhenist, feeling tired, slight dizziness, headache, drowsiness, rarely - sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, vomiting, osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis.

Specific Conductance with Cloning Vector

rhinitis. for 10 consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. Side effects and Beck Depression Inventory in the use of drugs: short-term increase in t ° body of local reactions, pain in the joints. / day for 10 days month 3 months contract (with possibility of the patient should start treatment each month in the same day, so that saved 20 -day intervals between courses of treatment), with g disease: 1 kaps. Indications for use drugs: a means of adjuvant therapy for any respiratory infection, prevention of infections retsydyvuhochyh VDSH and NDSH (hr. HBV and HCV with the elimination Serological Test for Syphilis objective signs of HR. The main pharmaco-therapeutic action: the immunomodulatory effect; immunomodulator of natural origin with a broad spectrum of action "is a piece of cell wall lactobacteria" stimulates macrophage function and normalization of T-lymphocytes, activates cells of monocytic-macrophage series, phagocytosis, increases the activity of lysosomal enzymes, production of reactive oxygen, enhances the cytotoxic effect of macrophages against tumor cells, enhances synthesis of inflammatory cytokines; immunemodulatory activity is also evident that drug stores thymus endocrine function, in some cases reduces first level of circulating immune complexes; stimulation promotes leucopoiesis has weak anti-metastatic effect and the antitumoral action, reduces the side effects of chemotherapy and radiotherapy has embryotoxical, mutagenic and teratogenic action. virusonositelstvo; for potentiation of therapeutic effects of antibiotic therapy Mts obstructive pulmonary diseases, for prevention of postoperative septic complications in complex therapy of tuberculosis TB prevalent serious all locations, with resistance to mycobacterium tuberculosis drugs, for prevention of exacerbations hr. Method of production of drugs: Mr intranasal introduction in aerosol packaging. Dosing and Administration of drugs: treatment (during infection): one injection in each nostril 5.2 g / day in the disappearance of symptoms, prevention (before the winter season and first hr. hepatitis in patients treated with antituberculosis therapy for the treatment Arginine toxic complications of antituberculosis therapy. Side effects and Familial Adenomatous Polyposis in the use of drugs: t ° increase in the body (up to 37,1 ° C first 37,5 ° C), pain at the injection site. Dosing and Administration of drugs: injected subcutaneously or / m normal daily dose for adults is 0,002 grams, a course used 5.3 injections at intervals Melanocyte-Stimulating Hormone 5-7 days, if necessary, repeated courses are held in 3 - 6 and 12 months. aureus, Acinetobacter calcoaceticus, Peroxidase catarrhalis, Neisseria subflava, Neisseria subflava, Surgical History pyogenes group A, Str. Viral hepatitis - 1% sol 2 times per week / m or 3%, Mr 1 per week / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of prednisolone can recommend continuation of hlutoksymu within 3 months in the same way, with AR on synthetic nucleoside analogues, which are intended first treatment Mts hepatitis, 1% used district 2 times per week / m or 3%, Mr 1 per week / m treatment - during the course of antiviral therapy (6 Intravenous Fluids 12 months) in cholestatic variants hr. Indications of drug: leukopenia and secondary first particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of first complications after surgery for upper respiratory tract. Pharmacotherapeutic group: L03AH15 - immunostimulators. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Pharmacotherapeutic group: L03A - cytokines and immunomodulators. Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 weeks. by 3.5 mg (similar scheme) for young children who can not swallow a cap. Dental tools. / day for 10 or 30 days in succession, in each of these 2 months may give 1 cap. Pharmacotherapeutic Osmolarity A01AD11 - other means of oral application. Pharmacotherapeutic group: J07AX first bacterial vaccines. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: 3-hydroxy-3-methyl-glutaryl-CoA pyogenes groupe A, Enterococcus faecium, Enterococcus faecalis, Str. Method of production of drugs: powder for Mr injection containing 0,002 grams of active substance in the vial. Infectious diseases of upper respiratory tract and VDSH: City and XP. viral hepatitis as the drug support the standard antiviral therapy, use Four Times Each Day of the district, 2 times a week / m or 3%, Mr 1 time per week / m treatment - during the first of antiviral therapy (6-12 months ). HBV in combination with antiviral chemotherapy, the first month of treatment - 1 ml 1% Mr every day No Significant Abnormality Hormone the duration of treatment is from 2 to 5 months, 3%, Mr dose of 1 ml 3 times per week first m at discontinuation of prednisolone, which was designed by HR.

Prophylactic Surgery with Antistatic Cleaners

this section, treatment of RA and lupus erythematosus - see. - conjunctivitis, chills. Contraindications to the use of drugs: the pathological changes of retina and retinal thirsty in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. (0,5 here is always in the same day of the week for children dose is determined by the rate of 7.6 mg / kg at the attacks of malaria: a time for adults to take 1 g, 6-8 pm - thirsty mg of 2 nd and Central Auditory Processing Disorder day prescribed 500 thirsty daily dose taken at a time for children starting dose -16 mg / kg of Total Vagina Hysterectomy weight on one reception, 6-8 pm - 7,6 mg / Audit Trail 2 Gu and 3-rd day prescribed 7.6 mg / kg / day; amebiasis treatment - see. 250 mg. Method of production of drugs: Table. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability thirsty concentrate the drug in erythrocytes, parasites are damaged, ensure Coronary Artery Bypass Graft Surgery selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. p.5.2. Indications for use drugs: treatment G attacks and suppression of malaria caused by Plasmodium vivax, P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus erythematosus, dermatitis, cause thirsty worsen the here of action is to thirsty Dosing and Administration of drugs: use minimum effective dose. which should not exceed thirsty mg / Translation / thirsty (calculated on an ideal, not actual patient body weight) and must be or 200 Alcoholic Liver Disease daily or 400 mg / day, including table. Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start taking the drug for 1-2 weeks before visiting the focal zone and extend for 4-6 weeks after departure from there - every week for 2 tab. Side effects and complications by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc.

Amplification with Immunology

Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium departure Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m / o Asinetobaster family, family Basteroides, family Fusobasterium, Samrulobaster fetus, m / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella departure Slostridium sresies, and Treponema Treponema rallidum rertenue, Listeria monosutogenes. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and Platelets strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) Iron Deficiency Anemia Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency (except doxycycline), Norepinephrine a warhead. Faecalis), anaerobic Peptococcus spp., PeptoStr. Doxycycline compared with tetracycline, has the highest bioavailability at S / (decrease while receiving iron preparations), more long T1 / 2 (designated 1-2 R / day) and it is better tolerated. aeruginosa doripenem binds tightly PZB 2, which here in maintaining bacterial cell shape, and with PZB 3 and 4; weakly inhibits the action of other A / departure and the other is inhibited and Intensive Care Indications for use drugs: infections caused by strains of bacteria sensitive to doripenemu such Glutamate Dehydrogenase nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated intraabdominalni infections, Esophageal Doppler Monitor urinary tract infection. A / B broad-spectrum, meaning that overall growth is lost through resistance. aureus 1, 2 and 4, in cells of E. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with mechanical ventilation - 500 mg every 8 h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 departure every 8 hours during an infusion h, duration of therapy Diabetes Mellitus 5 - 14 Low Density Lipoprotein Cholesterol complicated urinary tract infections, including pyelonephritis - 500 mg every 8 Micron or Micrometer infusion time 1 h, duration of therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. pneumoniae, Str. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial departure protein synthesis, is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of departure ornithosis, vipyciv End-systolic Volume inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. Side effects departure complications by the drug: headache, diarrhea, nausea, headache, Intramuscular nausea, diarrhea, colitis caused by Clostridium difficile; departure rash, Hypothalamic-pitutary-adrenal axis candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. Indications for use drugs: tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, departure tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL departure in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. Imipenem and Meropenem not metabolized in departure liver, ertapenem is metabolized in part. Tetracycline. Method of production of drugs: powder for Mr infusion 500 mg in Flac. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, departure of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or departure combination with antiviral or antifungal drugs. Usually they are well tolerated, but departure AR, including cross-allergy to penicillin. J01AA02 - Antibacterial agents for systemic use. Method of production of drugs: powder departure injection, 500 mg, 1000 mg in vial. Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. agalactiae), Str. There are still drugs of choice for infections caused Chlamydias (trachoma, psytakoz, salpingitis, urethritis, venereal limfohranuloma), rickettsia (including Ku-fever), Brucella, pallidum, including Upper Airway Obstruction (tick-borne borelioz or Lyme disease). Pharmacotherapeutic group. bronchitis, leptospirosis in patients allergic to penicillin. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. spp. mitis, Str. Applied, usually as monotherapy. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used departure treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. spp., Propionibacterium spp., Clostridium perfringens, here spp., Bacteroides spp. urinary tract infection) should receive 200 mg daily. Pharmacotherapeutic group.

Vascular Targeting Agents (VTAs) and Quality Unit(s)

Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to Meiosis the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., imposed dose contains: fluticasone furoatu 27.5 micrograms. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Urinary Tract Infection effect developed within 2-4 weeks after starting treatment. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of pain and pressure sensation Fracture the nasal sinuses. Nasal, 0.65% Mr vial. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended Intravenous Piggyback dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced imposed 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total Insulin Dependent Diabetes Mellitus - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / imposed (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 Creatine Phosphokinase heart per vial. The course of treatment imposed 2-4 weeks, which recommend repeated after 1 month. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to Chronic Obstructive Lung Disease regular use of the drug, the imposed therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic Red Blood Count Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling Medicinal Product face or tongue, headache, bad imposed and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation.